Exact Sciences Corporation (FRA:EXK)
86.94
+0.42 (0.49%)
At close: Jan 9, 2026
Exact Sciences Employees
As of December 31, 2024, Exact Sciences had 7,000 total employees, including 6,900 full-time and 100 part-time employees. The number of employees increased by 400 or 6.06% compared to the previous year.
Employees
7,000
Change (1Y)
400
Growth (1Y)
6.06%
Revenue / Employee
€377,959
Profits / Employee
€120,987
Market Cap
16.66B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7,000 | 400 | 6.06% |
| Dec 31, 2023 | 6,600 | 200 | 3.13% |
| Dec 31, 2022 | 6,400 | -100 | -1.54% |
| Dec 31, 2021 | 6,500 | 1,500 | 30.00% |
| Dec 31, 2020 | 5,000 | 890 | 21.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 317,562 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,995 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Exact Sciences News
- 4 days ago - Exact Sciences: Abbott Acquisition A Positive Sign For Oncology Diagnostics - Seeking Alpha
- 6 days ago - EXAS Stock Rating Downgraded to 'In-Line' by Evercore ISI Group | EXAS Stock News - GuruFocus
- 9 days ago - Top 2 Health Care Stocks That May Crash In Q1 - Benzinga
- 12 days ago - Exact Sciences Shareholders Unhappy With $105 Per Share Sale to Abbott Should Contact Julie & Holleman LLP Regarding Potential Claims - GlobeNewsWire
- 12 days ago - Should You Continue to Hold EXAS Stock in Your Portfolio Now? - Nasdaq
- 15 days ago - EXAS Quantitative Stock Analysis - Nasdaq
- 23 days ago - XBI, EXAS, RVMD, RNA: Large Outflows Detected at ETF - Nasdaq
- 4 weeks ago - Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect MRD Test in Early Triple-Negative Breast Cancer at SABCS - Wallstreet:Online